Global, Healthcare | Corporate Finance Advisory

Armstrong Pharma Acquired by Medeva

Armstrong Pharmaceuticals, Inc. (NASDAQ) is a leading producer of drug delivery systems including inhalation therapeutics devices
Armstrong retained TM Capital as financial advisor in connection with Armstrong’s $52 million stock swap merger with Medeva plc (LSE)
TM Capital also provided a fairness opinion to the board of directors of Armstrong in connection with the merger with Medeva

has been acquired through a stock swap merger by

Armstrong Pharma Acquired by Medeva

TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE)

For more information, contact our healthcare team at:

healthcare@tmcapital.com

Client Testimonial

”